Text Size

Air Fluidized Therapy (AFT) in Patients With Suspected Deep Tissue Injury (sDTI)

This study has been completed.
Sponsor:
Information provided by:
Hill-Rom
ClinicalTrials.gov Identifier:
NCT01292980
First received: February 8, 2011
Last updated: February 10, 2011
Last verified: February 2011
History of Changes
  Purpose

Patients with a suspected Deep Tissue Injury (or a purple reddened area over a bony prominence of their body, which is expected to break down into a pressure ulcer) will be place on the Clinitron® Rite HiteTM bed to see if the air fluidized mattress decreases the amount of tissue breakdown from their bruise.


Condition Intervention
Pressure Ulcers
 Device: AFT bed

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Air Fluidized Therapy Use in Patients Who Present With Suspected Deep Tissue Injury - a Case Series

Resource links provided by NLM:

MedlinePlus related topics: Pressure Sores
U.S. FDA Resources

Further study details as provided by Hill-Rom:

Primary Outcome Measures:
  • Degree of breakdown [ Time Frame: 21 days ] [ Designated as safety issue: No ]
    This case series seeks to identify patients with suspected DTI and capture actual patient outcomes with AFT treatment


Enrollment: 5
Study Start Date: August 2010
Study Completion Date: February 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: AFT bed
    All identified patients will receive a AFT bed for a maximum of 21 days or until discharge
    Other Name: Clinitron® Rite HiteTM bed
Detailed Description:

Up to 15 centers will participate in this case series in acute care and long term acute care facilities. Patients who present with sDTI and consent for study will have the Clinitron® Rite HiteTM bed ordered and delivered within a 12 hour window to be able to participate. They will have their sDTI photographed, and an assessment of expected breakdown will be noted by the clinical team. The patient will be followed during the course of hospitalization and additional photographs and documentation will be performed by the clinical team to demonstrate the actual breakdown that occurred.

Information including the pertinent history of current illness, co-morbid conditions, and demographic information will be shared with the sponsor in order to demonstrate each case.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who present to the hospital with SDTI

Criteria

Inclusion Criteria:

  1. Patients with sDTI on the supine aspect of their body
  2. Patient does not require a pulmonary specialty bed for care
  3. Patient is expected to be in the hospital for at least 3 days
  4. Patient weighs between 30 and 350 Lbs.
  5. Patient's height is less than 75 inches tall
  6. Patient, or patient's representative, is willing and able to sign written informed consent
  7. Patient is expected to survive hospitalization.

Exclusion Criteria:

  1. Patient is less than 18 years of age
  2. Patient has already participated in this study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01292980

Locations
United States, Texas
Harris Methodist Hospital
Ft. Worth, Texas, United States, 76104
Sponsors and Collaborators
Hill-Rom
  More Information

No publications provided

Responsible Party: Catherine VanGilder, Hill-Rom
ClinicalTrials.gov Identifier: NCT01292980     History of Changes
Other Study ID Numbers: CR-2009-08
Study First Received: February 8, 2011
Last Updated: February 10, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Hill-Rom:
sDTI
Pressure ulcers
Therapy surfaces
 Mattresses
Deep Tissue Injury
pressure ulcer treatment

Additional relevant MeSH terms:
Pressure Ulcer
Ulcer
Skin Ulcer
Skin Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on May 19, 2013